ATBECHDEDKESFRGBGRITLILUNLSEMC......................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0575500A119931229EP92908310.01992030719930907enenen1991066629219910308US1993122919935219931229199352

A61K 31/ 16 A I

A61K 31/ 19 A I

A61K 31/ 195 A I

A61K 31/ 22 A I

A61P 31/ 12 A I

A61P 31/ 18 A I

A61P 37/ 04 A I

A61P 43/ 00 A I

C07C 221/ 00 A I

C07C 225/ 02 A I

C07C 233/ 30 A I

C07C 233/ 47 A I

C07C 237/ 12 A I

C07C 237/ 22 A I

C07C 271/ 06 A I

C07C 271/ 22 A I

C07C 311/ 32 A I

C07K 5/ 02 A I

A61K 38/ 00 A N

enHIV PROTEASE INHIBITORSfrAGENTS INHIBITEURS DE PROTEASE DE L'HIVdeHIV-PROTEASEINHIBITORENSMITHKLINE BEECHAM CORPORATIONCorporate Patents, Swedeland Road, P.O. Box 1539King of Prussia, PA 19406USGLEASON, John, Gerald8 Heron Hill DriveDowningtown, PA 19335USLUM, Robert, Thomas292 Iven Avenue, Apt. 3CSt. Davids, PA 19087USTocher, Pauline, et alSmithKline Beecham plc Corporate Intellectual Property SB House Great West RoadBrentford, Middlesex TW8 9BDGBATBECHDEDKESFRGBGRITLILUMCNLSEUS199200173819920307enWO199201531919920917199224